A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
BioNTech SE
BioNTech SE
National Cancer Institute (NCI)
OncoC4, Inc.
University of Florida
DualityBio Inc.
University of Nebraska